BackVBI Vaccines Overview

VBI Vaccines Current Cash

Track VBI Vaccines's current cash ($13M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$12.60M
↓ 68.82% YoYΔ $-27.80M vs prior year quarter

Peer average

Loading

VBI Vaccines Current Cash History

Loading

VBI Vaccines vs. peers: Current Cash Comparison

Loading

VBI Vaccines Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

VBI Vaccines (VBIV) FAQ

VBI Vaccines (VBIV) currently reports a current cash of $13M as of March 2024. That compares with $40M in the prior-year period — down 68.8% year over year. Use the charts on this page to explore VBI Vaccines's current cash history and peer comparisons.

VBI Vaccines's current cash decreased from $40M to $13M — a 68.8% year-over-year decrease (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

VBI Vaccines reported $13M in current cash as of March 2024. That compares with $40M in the prior-year period — down 68.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $13M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for VBI Vaccines, and consider following VBIV for alerts when major investors trade the stock.

VBI Vaccines is classified in the Healthcare sector. On current cash, it currently shows $13M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing VBIV with unrelated industries.